113 related articles for article (PubMed ID: 36426068)
41. Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China.
Huang W; Yang J; Liu Y; Liu C; Zhang X; Fu W; Shi L; Liu G
BMJ Open; 2018 Dec; 8(12):e022711. PubMed ID: 30530472
[TBL] [Abstract][Full Text] [Related]
42. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
Park EH; Strand V; Oh YJ; Song YW; Lee EB
Arthritis Res Ther; 2019 Feb; 21(1):61. PubMed ID: 30770765
[TBL] [Abstract][Full Text] [Related]
43. Comparison of EQ-5D-5L and SPVU-5D for measuring quality of life in patients with venous leg ulcers in an Australian setting.
Cheng Q; Kularatna S; Lee XJ; Graves N; Pacella RE
Qual Life Res; 2019 Jul; 28(7):1903-1911. PubMed ID: 30778889
[TBL] [Abstract][Full Text] [Related]
44. Quality of life profile of general Vietnamese population using EQ-5D-5L.
Nguyen LH; Tran BX; Hoang Le QN; Tran TT; Latkin CA
Health Qual Life Outcomes; 2017 Oct; 15(1):199. PubMed ID: 29020996
[TBL] [Abstract][Full Text] [Related]
45. Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P.
Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Hino A; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Noto S; Shimozuma K
Qual Life Res; 2019 Sep; 28(9):2383-2391. PubMed ID: 31025290
[TBL] [Abstract][Full Text] [Related]
46. Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease.
Alexander S; Swami U; Kaur A; Gao Y; Fatima M; Ginn MM; Stein JE; Grivas P; Zakharia Y; Singh N
Ann Transl Med; 2021 Jun; 9(12):1033. PubMed ID: 34277833
[TBL] [Abstract][Full Text] [Related]
47. Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single-Center Cohort of Sixty-One Patients.
Richter MD; Crowson C; Kottschade LA; Finnes HD; Markovic SN; Thanarajasingam U
Arthritis Rheumatol; 2019 Mar; 71(3):468-475. PubMed ID: 30281202
[TBL] [Abstract][Full Text] [Related]
48. An Insight Into the Health-Related Quality of Life of Adolescent Idiopathic Scoliosis Patients Who Are Braced, Observed, and Previously Braced.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 May; 44(10):E596-E605. PubMed ID: 31046000
[TBL] [Abstract][Full Text] [Related]
49. Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events.
Poto R; Troiani T; Criscuolo G; Marone G; Ciardiello F; Tocchetti CG; Varricchi G
Front Immunol; 2022; 13():804597. PubMed ID: 35432346
[TBL] [Abstract][Full Text] [Related]
50. Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey.
Hołownia-Voloskova M; Tarbastaev A; Golicki D
Qual Life Res; 2021 Mar; 30(3):831-840. PubMed ID: 33237551
[TBL] [Abstract][Full Text] [Related]
51. Validation of the Mobile App Version of the EQ-5D-5L Quality of Life Questionnaire Against the Gold Standard Paper-Based Version: Randomized Crossover Study.
Kamstra RJM; Boorsma A; Krone T; van Stokkum RM; Eggink HM; Peters T; Pasman WJ
JMIR Form Res; 2022 Aug; 6(8):e37303. PubMed ID: 35969437
[TBL] [Abstract][Full Text] [Related]
52. Examining the health-related quality of life using EQ-5D-5L in patients with four kinds of chronic diseases from specialist outpatient clinics in Hong Kong SAR, China.
Xu RH; Cheung AWL; Wong EL
Patient Prefer Adherence; 2017; 11():1565-1572. PubMed ID: 28979104
[TBL] [Abstract][Full Text] [Related]
53. Efficacy, prognosis and safety analysis of anti-PD-1/PD-L1 inhibitor rechallenge in advanced lung cancer patients: a cohort study.
Yang J; Zeng R; Zhou J; Luo L; Lyu M; Liu F; Sun X; Zhou L; Wang X; Bao Z; Chen W; Dumoulin DW; Gao B; Xiang Y
Transl Lung Cancer Res; 2022 Jun; 11(6):1038-1050. PubMed ID: 35832441
[TBL] [Abstract][Full Text] [Related]
54. Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
J Neurol Sci; 2015 Nov; 358(1-2):53-7. PubMed ID: 26276513
[TBL] [Abstract][Full Text] [Related]
55. A cross sectional survey on health-related quality of life among parents of children with allergic symptoms using the EQ-5D-5L.
Hwang TY; Kim SK; Kim SH; Kim M
J Asthma; 2019 Nov; 56(11):1239-1245. PubMed ID: 30702001
[No Abstract] [Full Text] [Related]
56. Outcome and risk factor of immune-related adverse events and pneumonitis in patients with advanced or postoperative recurrent non-small cell lung cancer treated with immune checkpoint inhibitors.
Isono T; Kagiyama N; Takano K; Hosoda C; Nishida T; Kawate E; Kobayashi Y; Ishiguro T; Takaku Y; Kurashima K; Yanagisawa T; Takayanagi N
Thorac Cancer; 2021 Jan; 12(2):153-164. PubMed ID: 33201587
[TBL] [Abstract][Full Text] [Related]
57. Immune checkpoint inhibitors-induced autoimmunity: The impact of gender.
Triggianese P; Novelli L; Galdiero MR; Chimenti MS; Conigliaro P; Perricone R; Perricone C; Gerli R
Autoimmun Rev; 2020 Aug; 19(8):102590. PubMed ID: 32561463
[TBL] [Abstract][Full Text] [Related]
58. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
59. The impact of hallux valgus on function and quality of life in females.
Lewis TL; Ray R; Gordon DJ
Foot Ankle Surg; 2022 Jun; 28(4):424-430. PubMed ID: 34344603
[TBL] [Abstract][Full Text] [Related]
60. Impact of asthma on women and men: Comparison with the general population using the EQ-5D-5L questionnaire.
Hernandez G; Dima AL; Pont À; Garin O; Martí-Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Ferrer M;
PLoS One; 2018; 13(8):e0202624. PubMed ID: 30138415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
